viernes, 25 de septiembre de 2020

Lorlatinib: Another First-Line Option for ALK-Positive NSCLC?

Lorlatinib: Another First-Line Option for ALK-Positive NSCLC?

Medscape Logo

Lorlatinib: Another First-Line Option for ALK-Positive NSCLC?

M. Alexander Otto
September 23, 2020

No hay comentarios:

Publicar un comentario